The Stop Corrupt Trading Act prohibits the President, Vice President, and their controlled businesses from selling or exchanging nonpublic information gained through their official positions for financial gain. This law defines nonpublic information as data that is confidential, exempt from public disclosure, or not available to the general public, and it bans anyone else from buying or selling such information for profit. Violators face criminal penalties including fines up to double the transaction value or up to five years in prison, as well as civil lawsuits that can result in the forfeiture of profits and significant monetary penalties. The bill also establishes a six-year statute of limitations for civil actions, which is paused while the President or Vice President holds office, and requires the Office of Government Ethics to refer credible evidence of violations to the Attorney General.
The Security And Freedom Enhancement Act of 2026, known as the SAFE Act, introduces new rules for how U.S. intelligence agencies collect and use information about Americans and people in the United States. The bill requires the FBI to conduct regular audits of its data queries, obtain additional approvals before searching for information about elected officials and judges, and create detailed records of all searches. It also limits when government agencies can access Americans' communications without a warrant and restricts intelligence agencies from purchasing personal data from private companies about people in the United States. The law increases transparency by requiring more detailed reports to Congress and the public about surveillance activities, and it expands the role of independent reviewers in court proceedings related to intelligence gathering.
This bill, known as the Stop Presidential Embezzlement Act, imposes a 100 percent federal tax on civil damages received by high-ranking government officials, including the President, Vice President, members of Congress, and top executive branch leaders. The tax applies specifically to money these officials receive from lawsuits filed against the United States government, covering settlements, verdicts, or judgments obtained during their tenure in office. The legislation amends the Internal Revenue Code to treat these damages as taxable income while simultaneously excluding them from gross income calculations, effectively creating a special tax category for this specific type of compensation. The changes take effect for any damages received after the bill is enacted, targeting financial recovery from civil actions rather than criminal penalties or other forms of compensation.
S 1668 prohibits senior U.S. government officials - including the President, Vice President, Members of Congress, and Senate-confirmed appointees - from issuing, sponsoring, or endorsing cryptocurrencies, tokens, or stablecoins for profit. It also bans acquiring similar financial interests through derivatives or investment funds, while allowing normal public market trading. Violations face civil penalties of up to 10% of the financial interest's value or profits gained, and criminal charges if losses exceed $1 million or personal financial gain occurs. The law applies during official service and for one year after leaving office.
Right to IVF Act This bill provides a statutory right to access fertility treatments (e.g., in vitro fertilization). Specifically, under the bill, individuals have the right to access fertility treatments and to make decisions about the use of their reproductive genetic material (e.g., embryos) without limitation or interference. Health care providers and insurers have the right to provide and cover these services, respectively. Manufacturers of applicable drugs or devices also have the right to provide these drugs or devices. The bill supersedes state laws that limit or otherwise interfere with the provision of fertility treatments as set out under this bill, including laws that require medically unnecessary procedures or services in conjunction with fertility treatments or that restrict the ability of individuals to receive fertility treatments based on marital status or sex (including sexual orientation or gender identity). The bill does not affect state health and safety regulations for medical facilities or health care providers that are in accordance with widely accepted and evidence-based medical standards and for which the purpose cannot be achieved in another, nonrestrictive manner. The Department of Justice may bring civil actions against states, individuals, or entities that implement or enforce limitations or requirements that violate this bill. Individuals and health care providers may also bring civil actions. In addition, the bill provides for coverage of fertility treatments under Medicare and Medicaid and for members of the uniformed services and veterans. It also requires private insurers that cover obstetrical services to also cover fertility treatments.
S 4973, the "No Kings Act," removes presidential and vice presidential immunity from federal criminal prosecution, requiring such cases to be handled in federal district courts with appeals limited to the D.C. Circuit. The bill specifically bars the Supreme Court from reviewing cases involving claims of presidential immunity for official acts, including dismissals of indictments or overturning convictions. It directly affects current and former presidents and vice presidents by subjecting them to the same federal criminal accountability as all other citizens. Key provisions prevent courts from considering whether alleged crimes were part of official duties unless Congress specifies otherwise, and clarify that state criminal laws remain applicable.
This bill (S 4554) is a non-binding resolution expressing Congress's "sense" that protections for abortion access should be supported after the *Dobbs* decision and that *Roe v. Wade* protections should be restored. It does not create new laws or change existing policies; it is solely a statement of congressional opinion. The resolution directly affects no individuals or entities, as it lacks legal force. Key provisions (Section 2) state Congress supports post-*Dobbs* reproductive health care access and aims to restore *Roe*-era protections, but these are declarative statements only.
S 4381, the Right to Contraception Act, establishes a federal statutory right for individuals to access contraceptives and contraception services without government interference, directly affecting people seeking care, healthcare providers (like doctors, nurses, and pharmacists), and state governments. It prohibits states or the federal government from implementing laws that restrict access to contraceptives, hinder providers from offering services, or single out contraceptive care for special restrictions. The bill preempts conflicting state laws and creates legal avenues for individuals or providers to sue to block violations, with courts required to invalidate such restrictive laws. It explicitly does not alter existing requirements for health insurance coverage of contraceptives under federal law.
This bill temporarily suspends the federal debt ceiling from enactment until December 31, 2024, allowing the government to borrow without restriction during this period. It directly affects the U.S. Treasury's ability to issue new debt to fund existing government obligations. The key mechanism is a temporary pause on the debt limit, with a special rule ensuring that debt issued before January 1, 2025, to cover commitments due before that date is counted toward the new limit. This avoids a potential default on existing financial obligations without changing the debt limit permanently.
SJRES 4 is a joint resolution that removes the 1972 deadline for states to ratify the Equal Rights Amendment (ERA), which was originally proposed in House Joint Resolution 208. It declares that the ERA is valid as part of the U.S. Constitution if ratified by three-fourths of states (38), regardless of the expired deadline. The resolution directly affects the ERA ratification process, making it possible for states to complete ratification without time constraints. As of 2023, 38 states had already ratified the ERA, and this resolution would finalize its inclusion in the Constitution if enacted.
S 701, the Women’s Health Protection Act of 2023, prohibits states from imposing restrictions on abortion that are more burdensome than those for comparable medical procedures. It protects access to abortion before fetal viability (when a fetus could survive outside the womb) by banning requirements like unnecessary in-person visits, medically inaccurate counseling, or facility restrictions not applied to similar care. Post-viability abortions remain protected when medically necessary to safeguard a patient’s life or health. The bill preempts conflicting state laws and ensures enforcement through federal courts to uphold these access protections for patients and health care providers.
This bill expands transparency requirements for the transportation fuel market by amending the Energy Independence and Security Act of 2007 to include a broader definition of "transportation fuel" (encompassing gasoline, distillate fuels, jet fuel, aviation gasoline, and biofuels). It creates a new Transportation Fuel Monitoring and Enforcement Unit within the Federal Trade Commission to collect and analyze market data, while requiring the Department of Energy to gather detailed information from energy companies about crude oil and fuel production, transportation, storage, and pricing. Energy companies that own or control commercial amounts of these fuels must report specific market data, including quantities, prices, and sources of fuel. The bill establishes data-sharing agreements between federal agencies to improve regulatory oversight and requires the FTC to submit annual reports on enforcement actions related to market manipulation. These changes aim to promote transparent and competitive fuel markets while providing regulators with better data to identify potential market manipulation.
